{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T15:06:43Z","timestamp":1776956803236,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"1-3","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ejphar.2013.10.050","type":"journal-article","created":{"date-parts":[[2013,11,4]],"date-time":"2013-11-04T01:15:40Z","timestamp":1383527740000},"page":"69-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["The 2-methoxy methyl analogue of salvinorin A attenuates cocaine-induced drug seeking and sucrose reinforcements in rats"],"prefix":"10.1016","volume":"720","author":[{"given":"Aashish S.","family":"Morani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Ewald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine M.","family":"Prevatt-Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas E.","family":"Prisinzano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bronwyn M.","family":"Kivell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2013.10.050_bib1","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/BF02532378","article-title":"Cyclazocine revisited","volume":"21","author":"Archer","year":"1996","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2013.10.050_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00213-008-1458-3","article-title":"Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats","volume":"203","author":"Baker","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2013.10.050_bib3","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1038\/sj.npp.1300811","article-title":"Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity?","volume":"30","author":"Bart","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2013.10.050_bib4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1124\/jpet.107.129023","article-title":"N-methylacetamide analog of salvinorin A: a highly potent and selective kappa-opioid receptor agonist with oral efficacy","volume":"324","author":"Beguin","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.10.050_bib5","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.bmcl.2011.11.128","article-title":"Differential signaling properties at the kappa opioid receptor of 12-epi-salvinorin A and its analogues","volume":"22","author":"Beguin","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2013.10.050_bib6","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1016\/j.bmcl.2005.03.113","article-title":"Synthesis and in vitro pharmacological evaluation of salvinorin A analogues modified at C(2)","volume":"15","author":"Beguin","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2013.10.050_bib7","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1124\/jpet.106.112417","article-title":"Effects of salvinorin A, a kappa-opioid hallucinogen, on a neuroendocrine biomarker assay in nonhuman primates with high kappa-receptor homology to humans","volume":"320","author":"Butelman","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.10.050_bib8","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/jpet.108.145342","article-title":"Unconditioned behavioral effects of the powerful kappa-opioid hallucinogen salvinorin A in nonhuman primates: fast onset and entry into cerebrospinal fluid","volume":"328","author":"Butelman","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.10.050_bib9","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1124\/jpet.112.193227","article-title":"Behavioral effects and central nervous system levels of the broadly available kappa-agonist hallucinogen salvinorin A are affected by p-glycoprotein modulation in vivo","volume":"341","author":"Butelman","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.10.050_bib10","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1038\/sj.npp.1301659","article-title":"Exposure to the selective kappa-opioid receptor agonist salvinorin A modulates the behavioral and molecular effects of cocaine in rats","volume":"33","author":"Chartoff","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2013.10.050_bib11","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1124\/jpet.103.059394","article-title":"Salvinorin A, an active component of the hallucinogenic sage Salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations","volume":"308","author":"Chavkin","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.10.050_bib1001","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/npp.2010.137","article-title":"The therapeutic potential of kappa-opioids for treatment of pain and addiction","volume":"36","author":"Chavkin","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2013.10.050_bib12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF00432175","article-title":"Reinstatement of cocaine-reinforced responding in the rat","volume":"75","author":"De Wit","year":"1981","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2013.10.050_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00433012","article-title":"Drug reinstatement of heroin-reinforced responding in the rat","volume":"79","author":"De Wit","year":"1983","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2013.10.050_bib14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00008877-200512000-00005","article-title":"Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse","volume":"16","author":"Fantegrossi","year":"2005","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.10.050_bib15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0006-8993(95)00306-B","article-title":"Kappa-opioid inhibition of morphine and cocaine self-administration in rats","volume":"681","author":"Glick","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2013.10.050_bib16","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1046\/j.1471-4159.1999.0731066.x","article-title":"The kappa-opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum","volume":"73","author":"Gray","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2013.10.050_bib17","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1016\/S0028-3908(00)00119-2","article-title":"Kappa-opioid receptor modulation of nicotine-induced behaviour","volume":"39","author":"Hahn","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2013.10.050_bib18","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/FBP.0b013e3283586189","article-title":"Antidepressive effects of the kappa-opioid receptor agonist salvinorin A in a rat model of anhedonia","volume":"23","author":"Harden","year":"2012","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.10.050_bib19","first-page":"150","article-title":"Development of behavioral sensitization to cocaine\u2014influence of kappa-opioid receptor agonists","volume":"275","author":"Heidbreder","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.10.050_bib20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0006-8993(93)90228-F","article-title":"The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat","volume":"616","author":"Heidbreder","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2013.10.050_bib21","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.neuroimage.2008.03.003","article-title":"Pharmacokinetics of the potent hallucinogen, salvinorin A in primates parallels the rapid onset and short duration of effects in humans","volume":"41","author":"Hooker","year":"2008","journal-title":"NeuroImage"},{"key":"10.1016\/j.ejphar.2013.10.050_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00210-008-0358-8","article-title":"Comparison of the diuretic effects of chemically diverse kappa opioid agonists in rats: nalfurafine, U50,488H, and salvinorin A","volume":"379","author":"Inan","year":"2009","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.10.050_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.57.1.1","article-title":"Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments","volume":"57","author":"Kreek","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2013.10.050_bib24","first-page":"812","article-title":"Effects of kappa opioid agonists on cocaine- and food-maintained responding by rhesus monkeys","volume":"286","author":"Mello","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.10.050_bib25","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pbb.2009.09.002","article-title":"Effect of kappa-opioid receptor agonists U69593, U50488H, spiradoline and salvinorin A on cocaine-induced drug-seeking in rats","volume":"94","author":"Morani","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2013.10.050_bib26","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/FBP.0b013e3283512c1e","article-title":"A single injection of a novel kappa opioid receptor agonist salvinorin A attenuates the expression of cocaine-induced behavioral sensitization in rats","volume":"23","author":"Morani","year":"2012","journal-title":"Behav. Pharmacol"},{"key":"10.1016\/j.ejphar.2013.10.050_bib27","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.bmc.2007.10.067","article-title":"Standard protecting groups create potent and selective kappa opioids: salvinorin B alkoxymethyl ethers","volume":"16","author":"Munro","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2013.10.050_bib28","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/FBP.0b013e328349fc1b","article-title":"Salvinorin B derivatives, EOM-Sal B and MOM-Sal B, produce stimulus generalization in male Sprague-Dawley rats trained to discriminate salvinorin A","volume":"22","author":"Peet","year":"2011","journal-title":"Behav. Pharmacol"},{"key":"10.1016\/j.ejphar.2013.10.050_bib29","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1126\/science.3016896","article-title":"Psychotomimesis mediated by kappa-opiate receptors","volume":"233","author":"Pfeiffer","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2013.10.050_bib30","first-page":"139","article-title":"Animal-model of depression","volume":"30","author":"Porsolt","year":"1979","journal-title":"Biomedicine"},{"key":"10.1016\/j.ejphar.2013.10.050_bib31","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1039\/c1md00192b","article-title":"Potential drug abuse therapeutics derived from the hallucinogenic natural product salvinorin A","volume":"2","author":"Prevatt-Smith","year":"2011","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejphar.2013.10.050_bib32","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.lfs.2005.09.008","article-title":"Psychopharmacology of the hallucinogenic sage Salvia divinorum","volume":"78","author":"Prisinzano","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2013.10.050_bib33","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1021\/cr0782269","article-title":"Salvinorin A analogs as probes in opiold pharmacology","volume":"108","author":"Prisinzano","year":"2008","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejphar.2013.10.050_bib34","doi-asserted-by":"crossref","first-page":"E592","DOI":"10.1208\/aapsj070361","article-title":"kappa Opioids as potential treatments for stimulant dependence","volume":"7","author":"Prisinzano","year":"2005","journal-title":"AAPS J."},{"key":"10.1016\/j.ejphar.2013.10.050_bib35","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1073\/pnas.182234399","article-title":"Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist","volume":"99","author":"Roth","year":"2002","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2013.10.050_bib36","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s002130051016","article-title":"U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking","volume":"144","author":"Schenk","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2013.10.050_bib37","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0893-133X(00)00190-1","article-title":"Effects of the kappa-opioid receptor agonist, U69593, on the development of sensitization and on the maintenance of cocaine self-administration","volume":"24","author":"Schenk","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.ejphar.2013.10.050_bib38","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0091-3057(00)00478-0","article-title":"Effect of the kappa-opioid receptor agonist, U69593, on reinstatement of extinguished amphetamine self-administration behaviour","volume":"68","author":"Schenk","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2013.10.050_bib39","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/syn.20191","article-title":"Pharmacokinetics of the plant-derived kappa-opioid hallucinogen salvinorin a in nonhuman primates","volume":"58","author":"Schmidt","year":"2005","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2013.10.050_bib40","series-title":"Modulation of the behavioral and neurochemical effects of psychostimulants by kappa-opioid receptor systems","first-page":"50","author":"Shippenberg","year":"2001"},{"key":"10.1016\/j.ejphar.2013.10.050_bib41","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.pharmthera.2007.06.011","article-title":"Dynorphin and the pathophysiology of drug addiction","volume":"116","author":"Shippenberg","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2013.10.050_bib42","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nprot.2012.044","article-title":"Using the rat forced swim test to assess antidepressant-like activity in rodents","volume":"7","author":"Slattery","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejphar.2013.10.050_bib43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejphar.2004.10.051","article-title":"Effects of the mixed-action kappa\/mu opioid agonist 8-carboxamidocyclazocine on cocaine- and food-maintained responding in rhesus monkeys","volume":"506","author":"Stevenson","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.10.050_bib44","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00213-003-1680-y","article-title":"Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats","volume":"172","author":"Todtenkopf","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2013.10.050_bib45","first-page":"147","article-title":"Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans","volume":"299","author":"Walsh","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.10.050_bib46","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1124\/jpet.107.132142","article-title":"2-methoxymethyl-salvinorin B is a potent kappa opioid receptor agonist with longer lasting action in vivo than salvinorin A","volume":"324","author":"Wang","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.10.050_bib47","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1124\/jpet.104.073668","article-title":"Comparison of pharmacological activities of three distinct kappa ligands (salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo","volume":"312","author":"Wang","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.10.050_bib48","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00213-010-1825-8","article-title":"The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse","volume":"210","author":"Wee","year":"2010","journal-title":"Psychopharmacology"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913008170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913008170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T22:50:58Z","timestamp":1539211858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299913008170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":49,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0014299913008170"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.10.050","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The 2-methoxy methyl analogue of salvinorin A attenuates cocaine-induced drug seeking and sucrose reinforcements in rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.10.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}